Beijing Tong Ren Tang Healthcare Investment Co. Ltd. Class H
HHKEX:26671.44
HKD
-0.04
(-3.03%)
ISIN
CNE1000078Q2
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
CNY
•
in mil. unless spec.Working Capital
CNY
•
in mil. unless spec.Growth Rates
CNY
•
in mil. unless spec.Semi-annual Revenue
CNY
•
in mil. unless spec.Semi-annual Earnings Per Share
CNY
•
in mil. unless spec.Semi-annual Dividends Per Share
CNY
•
in mil. unless spec.Company Description
- CEO
- Yan Lu
- Full Time Employees
- 920
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 5th Floor, Tower A Beijing BE China
- IPO Date
- Jul 7, 2026
- Website
- yiyang.tongrentang.com
- Similar Companies
- Business
- Beijing Tong Ren Tang Healthcare Investment Co., Ltd. (Ticker: 2667.HK) engages in the strategic development and investment activities of Tong Ren Tang’s healthcare and traditional Chinese medicine (TCM) businesses, with a focus on expanding high-quality healthcare products and services across diversified channels and geographic regions. The company concentrates on leveraging Tong Ren Tang’s brand heritage and distribution network to pursue value-added investments in healthcare assets, platforms, and services, including traditional Chinese medicine preparations, modern health foods, pharmaceutical products, and related medical services through strategic partnerships and joint ventures. Main products and services - Core healthcare product platforms: traditional Chinese medicine (TCM) preparations and extracts; modern pharmaceutical products derived from TCM or integrated with Western medicine approaches; health supplements and wellness products; plant-based and natural product formulations; and complementary health devices aligned with TCM principles. - Product categories and brands: TCM decoction pieces, ready-to-use granules and granulated extracts, qi and tonify formulations, specialty herbal blends, and branded health foods; co-branded products leveraging Tong Ren Tang’s marketplace credentials and distribution reach. - Service offerings and capabilities: healthcare investment management; strategic partnerships and alliance development; corporate venture participation; incubator and acceleration support for healthcare start-ups; asset and platform acquisitions in the healthcare space; distribution and channel development for health products across retail, e-commerce, and institutional channels. - Geographic reach of products and services: operations and distribution across China, with expanding exposure to select international markets through partnerships and cross-border ventures, leveraging Tong Ren Tang’s historical footprint and supply chain infrastructure. - Founding year and headquarters: established as a vehicle within the Tong Ren Tang ecosystem to drive healthcare investments; headquarters based in China, aligned with Tong Ren Tang Group’s corporate headquarters and ecosystem. Latest major company changes - Strategic partnerships and alliances: enters into collaborations with healthcare platforms, research institutions, and healthcare service providers to co-develop and commercialize TCM-based and integrated care solutions; forms joint ventures to expand clinical and product development capabilities. - Funding rounds and acquisitions: participates in or leads targeted investments and acquisitions in healthcare assets, platforms, and subsidiaries within the Tong Ren Tang ecosystem to scale up capabilities and market presence. - New product launches or service offerings: accelerates introduction of integrated health solutions combining TCM formulations with modern wellness services, and expands branded health supplement lines across key consumer channels. - Strategic shifts or business expansions: intensifies focus on high-growth segments such as branded health foods, nutraceuticals, and patient-centric care platforms; expands geographic reach through partnerships and regional distribution expansions. - Reorganizations or name changes: realigns corporate structure within the Tong Ren Tang healthcare investment framework to streamline governance and accelerate decision-making for portfolio companies. - Operational changes: strengthens governance and performance management across portfolio investments; enhances supply chain resilience and quality control in product development and manufacturing partnerships within the healthcare space. Industry context and segments - Industry: healthcare investment and corporate development within the broader Tong Ren Tang ecosystem, emphasizing traditional Chinese medicine, modern pharmaceuticals, nutraceuticals, and integrated wellness services. - Business segments: investment management and platform development; product development and branding for TCM-based and wellness products; distribution and channel management; strategic partnerships and joint ventures; potential clinical and research collaborations. - Target markets: consumer health and wellness customers; healthcare providers and institutional buyers; potential partnerships with research institutes, clinics, and hospital networks. - Geographic operations: China-focused with selective international exposure via partnerships and cross-border ventures; regional expansion in Asia-Pacific through distribution and co-development arrangements. - Corporate relationships: subsidiary structure within the Tong Ren Tang corporate family, leveraging Tong Ren Tang Group’s resources, brand equity, and supply chain capabilities. Illustrative note - The company acts as a specialized investment and platform arm within Tong Ren Tang, translating traditional knowledge and brand strength into modern healthcare products and services, while pursuing strategic collaborations, portfolio growth, and expanded market reach across defined geographies.